Search results
Moderna Has Big AI News. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 2 days agoAnd last year, it signed a deal with International Business Machines...already is making the entire company more efficient. The biotech could become an...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoShares of vaccine producers' stocks are trading higher Wednesday on reports indicating disease...
Vaccine makers receive stock boost after third human bird flu case in US
Newsweek· 23 hours agoShares in some companies that produce vaccines have seen stock boosts following a small number of...
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 2 days agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Penn researchers made an avian flu vaccine using a technique that created COVID vaccines
Philly.com· 22 hours agoUniversity of Pennsylvania researchers have developed an mRNA vaccine for the H5N1 avian flu drawing...
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Zacks via Yahoo Finance· 20 hours agoIn the past six months, shares of MRNA have rallied 108.94%. (See the last biotech stock roundup...
3 Cathie Wood Stocks to Buy Now: May 2024
InvestorPlace· 3 days agoCathie Wood’s ARK Invest funds were unstoppable in 2020 as investors piled into disruptive innovation stocks during the low-rate lockdown environment. After peaking in early 2021, the ARK funds ...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 4 days agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Arcturus Therapeutics’ (ARCT) Outperform Rating Reaffirmed at William Blair
ETF DAILY NEWS· 7 hours agoARCT has been the topic of a number of other research reports. Canaccord Genuity Group lowered their target price on shares of Arcturus Therapeutics from $87.00 to $86.00 and set a buy rating ...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 2 days agoThe stock, however, keeps going up. Moderna shares have climbed 20% just this week, and 45% since...
